[1] 陈万青,李贺,孙可欣,等.2014年中国恶性肿瘤发病和死亡分析[J].中国肿瘤, 2018,40(1):5-13. [2] Ovando-Vázquez C, Lepe-Soltero D, Abreu-Goodger C.Improving microRNA target prediction with gene expression profiles[J].BMC Genomics, 2016,17(1):364. [3] 夏文杰,游庆军,王洁,等.DNA甲基化调控肺腺癌微小RNA-145表达的分子机制[J].中华实验外科杂志, 2015,32(5):1078-1080. [4] Hata A, Lieberman J.Dysregulation of microRNA biogenesis and gene silencing in cancer[J].Sci Signal, 2015,8(368):3. [5] Xu L, Huang Y, Chen D, et al.Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer[J].Cancer Genet, 2014,207(5):214-220. [6] 邵仟仟,林国乐.2017.V1版《NCCN结直肠癌诊治指南》更新解读[J].中国全科医学, 2017,20(6):635-638. [7] 刘华,娄杰,刘晓英,等.微RNA-21和微RNA-146a在结直肠肿瘤中的表达及临床意义[J].中华消化杂志, 2015,35(7):470-475. [8] 陈伟.血清miR-21在结直肠癌诊断和预后判断中的价值[J].中华胃肠外科杂志, 2013,16(8):767. [9] 邓嘉秋,冯德魁,吕生辉,等.结直肠癌患者血清、粪便和癌组织中miR-21、miR-217、miR-29b和miR-92a-1的检测及其临床意义[J].中国肿瘤生物治疗杂志, 2018,25(1):85-88. [10] Cookson VJ, Bentley MA, Hogan BV, et al.Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours[J].Cell oncol, 2012,35(4):301-308. |